Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biocon | NSE | Healthcare | Biotechnology & Medical Research | ₹398.60B | 50x | -1.5 | ₹333.40 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.9% Upside | Upgrade to Pro+ | |
Biocon | BSE | Healthcare | Biotechnology & Medical Research | ₹393.93B | 49x | -1.5 | ₹330 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.9% Upside | Upgrade to Pro+ | |
Syngene International Ltd BO | BSE | Healthcare | Biotechnology & Medical Research | ₹273.59B | 54.6x | ₹683.90 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.8% Upside | Upgrade to Pro+ | ||
Syngene International Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹269.48B | 54.8x | ₹671.80 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.5% Upside | Upgrade to Pro+ | ||
Suven Life Sciences | BSE | Healthcare | Biotechnology & Medical Research | ₹25.74B | -17.8x | 0.55 | ₹117.60 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Suven Life Sciences Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹25.74B | -17.8x | 0.55 | ₹117.54 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shree Ganesh Remedies | BSE | Healthcare | Biotechnology & Medical Research | ₹9.05B | 32x | 1.18 | ₹707 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Indo Us Bio-Tech | BSE | Healthcare | Biotechnology & Medical Research | ₹3.51B | 26.6x | 0.43 | ₹175 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Take Solutions | BSE | Healthcare | Biotechnology & Medical Research | ₹1.37B | -2x | 0.32 | ₹9.40 | -4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Take Solutions Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹1.37B | -2x | 0.32 | ₹9.30 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jeevan Scientific Technology | BSE | Healthcare | Biotechnology & Medical Research | ₹680.86M | 106.2x | 0.84 | ₹43 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivo Bio Tech | BSE | Healthcare | Biotechnology & Medical Research | ₹600.30M | 7.8x | 0.15 | ₹36.97 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Transgene Biotek | BSE | Healthcare | Biotechnology & Medical Research | ₹293.99M | -125.5x | -1.52 | ₹3.90 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vanta Bioscience | BSE | Healthcare | Biotechnology & Medical Research | ₹191.57M | -5x | -0.36 | ₹30.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |